학술논문

Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk
Document Type
Article
Source
In The Lancet Regional Health - Europe March 2024 38
Subject
Primary Research
Articles
Language
ISSN
2666-7762